ABPO
Abpro Holdings, Inc.Company Information
- Company Name
- Abpro Holdings, Inc.
- CIK
- CIK0001893219
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- ABPO: OTC, ABPWW: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2836
- SIC Description
- Biological Products, (No Diagnostic Substances)
- Ticker
- ABPO
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-07-31
- Last sale
- —
- Shares purchased (TTM)
- 119,102
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2025-12-31
- Institutional shares owned
- 46,543
- Shares outstanding
- 2,232,610
- Ownership
- 2.08%
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- 7.01%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Class A | - | - | - | - | - | - | - | 0 | - | - | - | 7 | ||||||
| Series F Convertible Preferred Stock | - | - | - | - | - | - | 0 | - | - | - | 9 | - | ||||||
| Related Party | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | 2 | - | ||||||
Assets | ||||||||||||||||||
| Common Class B | - | - | - | - | - | - | - | 0 | - | - | - | 0 | ||||||
| Series E Convertible Preferred Stock | - | - | - | - | - | - | 0 | - | - | - | 9 | - | ||||||
| Series D Convertible Preferred Stock | - | - | - | - | - | - | 0 | - | - | - | 3 | - | ||||||
| Cash | 4 | 5 | 0 | 0 | 2 | 1 | 3 | 0 | 0 | 0 | - | - | ||||||
| Accounts Receivable Net Current | - | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | ||||||
| Deferred Offering Costs | - | - | - | - | - | - | - | - | - | - | 1 | - | ||||||
| Series C Convertible Preferred Stock | - | - | - | - | - | - | 0 | - | - | - | 4 | - | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 5 | 7 | 1 | 1 | 3 | 2 | 4 | 2 | 0 | 0 | 30 | 1 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 1 | 0 | 1 | 1 | 0 | 0 | - | - | - | 0 | - | ||||||
| Series B Convertible Preferred Stock | - | - | - | - | - | - | 0 | - | - | - | 1 | - | ||||||
| Series A Redeemable Convertible Preferred Stock | - | - | - | - | - | - | 0 | - | - | - | 4 | - | ||||||
| Security Deposit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | ||||||
| Restricted Cash Current | - | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | ||||||
| Cash And Cash Equivalents At Carrying Value | - | - | - | - | - | - | 3 | 0 | 0 | 0 | 0 | 1 | ||||||
| Prepaid Expense Current | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Held In Trust Current | - | - | - | - | - | - | - | 1 | 0 | 0 | 30 | - | ||||||
| Assets Held In Trust Noncurrent | - | - | - | - | - | - | - | 6 | 8 | 8 | 7 | 36 | ||||||
| Property Plant And Equipment Net | - | - | - | - | 0 | 0 | 0 | - | - | - | 0 | - | ||||||
| Operating Lease Right Of Use Asset | - | - | - | - | 0 | 0 | 0 | - | - | - | 1 | - | ||||||
| Assets | 5 | 7 | 1 | 2 | 3 | 3 | 5 | 8 | 8 | 8 | 37 | 38 | ||||||
| Accounts Payable And Accrued Liabilities Current | - | - | - | - | - | - | - | 2 | 2 | 1 | - | - | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Shares Subject To Mandatory Redemption Settlement Terms Amount Current | - | - | - | - | - | - | - | - | 0 | 0 | 30 | - | ||||||
| Taxes Payable Current | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 2 | ||||||
| Other Liabilities Current | - | - | - | - | - | - | - | 2 | - | - | - | - | ||||||
| Accounts Payable Current | 4 | 5 | 5 | 5 | 5 | 5 | 4 | - | - | - | 8 | - | ||||||
Liabilities Current | ||||||||||||||||||
| Accrued Liabilities Current | 4 | 4 | 4 | 8 | 8 | 8 | 7 | - | - | - | 0 | 1 | ||||||
| Liabilities Current | 8 | 9 | 9 | 17 | 20 | 21 | 20 | 9 | 7 | 7 | 35 | 6 | ||||||
| Sales And Excise Tax Payable Current | - | - | - | 4 | 4 | 4 | 4 | - | - | - | - | - | ||||||
| Operating Lease Liability Current | - | - | - | - | 0 | 0 | 0 | - | - | - | 1 | - | ||||||
| Finance Lease Liability Current | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
| Operating Lease Liability Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
| Deferred Compensation Liability Classified Noncurrent | - | - | - | - | - | - | - | - | 11 | 11 | 11 | 11 | ||||||
| Accrued Income Taxes Current | - | - | - | - | 0 | 0 | 0 | - | - | - | - | - | ||||||
| Convertible Notes Payable Current | - | - | - | - | - | 3 | 3 | - | - | - | - | - | ||||||
| Notes Payable Current | - | - | - | - | 0 | - | 0 | - | - | - | - | - | ||||||
| Embedded Derivative Fair Value Of Embedded Derivative Liability | - | - | - | - | 0 | 0 | 0 | - | - | - | - | - | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | -4 | -2 | -9 | -16 | -17 | -18 | -15 | -18 | -89 | -17 | -16 | -15 | ||||||
| Common Stock Value | 0 | 0 | - | - | 0 | 0 | 0 | - | - | - | 0 | - | ||||||
| Treasury Stock Value | - | - | - | - | - | - | - | - | - | - | -0 | - | ||||||
| Additional Paid In Capital | 117 | 117 | 110 | 108 | 105 | 102 | 101 | - | 0 | 0 | 0 | 0 | ||||||
| Retained Earnings Accumulated Deficit | -121 | -120 | -119 | -125 | -123 | -120 | -116 | -18 | -17 | -17 | -16 | -15 | ||||||
| Liabilities | - | - | - | - | - | - | 20 | 20 | 18 | 17 | 46 | 16 | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | - | - | - | - | - | - | - | 6 | 7 | 7 | 7 | 37 | ||||||
| Preferred Stock Value | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | ||||||
| Minority Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | - | - | 1 | - | ||||||
Features Of Convertible Preferred Stock | ||||||||||||||||||
| Liabilities And Stockholders Equity | 5 | 7 | 1 | 2 | 3 | 3 | 5 | 8 | 8 | 8 | 37 | 38 | ||||||
| Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
| Temporary Equity Shares Issued | - | - | - | - | - | - | - | 1 | - | - | - | - | ||||||
| Temporary Equity Shares Outstanding | - | - | - | - | - | - | - | 1 | - | - | - | - | ||||||
| Temporary Equity Redemption Price Per Share | - | - | - | - | - | - | - | 11.32 | - | - | - | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | 0.00 | - | ||||||
| Common Stock Shares Authorized | 110 | 110 | 110 | 110 | 110 | 110 | 110 | - | - | - | 82 | - | ||||||
| Common Stock Shares Issued | 6 | 6 | 3 | 3 | 2 | 2 | 2 | - | - | - | 1 | - | ||||||
| Shares Outstanding | 6 | 6 | 3 | 3 | 2 | 2 | 2 | - | - | - | 1 | - | ||||||
| Treasury Stock Common Shares | - | - | 0 | 0 | 1 | 1 | 0 | - | - | - | 0 | - | ||||||
| Temporary Equity Par Or Stated Value Per Share | - | - | - | - | - | - | 0.00 | - | - | - | 0.00 | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialAbpro Holdings, Inc. (ABPO) — SEC Financial Statements & Analysis
Abpro Holdings, Inc. (ABPO) is a biological products, (no diagnostic substances) company, incorporated in DE. Abpro Holdings, Inc. trades on OTC as: ABPO, ABPWW. Abpro Holdings, Inc. (ABPO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, On profitability, Abpro Holdings, Inc. posts an operating margin of -5421.31%, a net margin of -7691.88%, a Return on Equity (ROE) of -20.18%, and a Return on Assets (ROA) of 46.10%. Per share, it reports EPS of $0.34, diluted EPS of $0.34, free cash flow per share of $-1.12, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of -114.29% year-over-year, and EPS growth of -104.65% year-over-year. On the balance sheet, it maintains a current ratio of 0.62x, a quick ratio of 0.52x, working capital of $-3.15M, a debt-to-equity ratio of -2.76x, a debt ratio of 1.57, an interest coverage ratio of -20.31x, free cash flow of $-6.59M (TTM), and net debt of $-4.24M. Figures sourced from SEC EDGAR.
- EPS TTM
- $0.34
- ROE TTM
- -20.18%
- ROA TTM
- 46.10%
- Debt To Equity
- -2.76x
- Free Cash Flow TTM
- $-6.59M
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Abpro Holdings, Inc. in?
Abpro Holdings, Inc. (ABPO) operates in the Biological Products, (No Diagnostic Substances) industry.
What exchange does ABPO trade on?
Abpro Holdings, Inc. (ABPO) trades on the OTC.
Where is Abpro Holdings, Inc. incorporated?
Abpro Holdings, Inc. is incorporated in DE.
When was Abpro Holdings, Inc. (ABPO)'s most recent SEC filing?
Abpro Holdings, Inc. (ABPO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is ABPO's EPS (earnings per share)?
Abpro Holdings, Inc. (ABPO)'s trailing twelve month EPS is $0.34 as of 2026-06-30.
What is ABPO's ROE (return on equity)?
Abpro Holdings, Inc. (ABPO)'s trailing twelve month Return on Equity (ROE) is -20.18% as of 2026-06-30.
What is ABPO's ROA (return on assets)?
Abpro Holdings, Inc. (ABPO)'s trailing twelve month Return on Assets (ROA) is 46.10% as of 2026-06-30.